Vimarsana
Biggest News Aggregation in the World

Page 8 - Risk Stratification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Risk Stratification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Risk Stratification Today - Breaking & Trending Today

DiamiR Biosciences Announces Two Poster Presentations at 2023 Alzheimer's Association International Conference - Vimarsana News

DiamiR Biosciences Announces Two Poster Presentations at 2023 Alzheimer's Association International Conference

/PRNewswire/ -- DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced...

Risk Stratification of Myelodysplastic Syndromes [MDS] - Vimarsana News

Risk Stratification of Myelodysplastic Syndromes [MDS]

Ralph Boccia, MD, FACP, and Hetty Carraway, MD, review Myelodysplastic Syndromes [MDS] risk stratification criteria used in their practices.

The Role of Vedolizumab and Risankizumab in CD - Vimarsana News

The Role of Vedolizumab and Risankizumab in CD

Anita Afzali, MD, David Hudesman, MD, Millie Long, and Miguel Regueiro, MD, discuss Vedolizumab and Risankizumab as treatments for Crohn’s Disease (CD).

Selecting First-Line Treatments for CD - Vimarsana News

Selecting First-Line Treatments for CD

David Hudesman, MD, Miguel Regueiro, MD, and Maia Kayal, MD, offer first line treatment strategies for patients with Crohn’s Disease (CD).

Optellum's Clinical Partners Present at ATS International Conference 2023 - Vimarsana News

Optellum's Clinical Partners Present at ATS International Conference 2023

/PRNewswire/ -- Optellum, a medtech company that provides a ground-breaking AI platform to diagnose and treat early-stage lung cancer, is attending this year's...